Stephanie Yao
Nessuna posizione attualmente
Profilo
Stephanie Yao is Vice President-Communications & Investor Relations at Graphite Bio, Inc. In her past career Ms. Yao occupied the position of Executive Director-Investor Relations at Kronos Bio, Inc. and Investor Relations Contact at Global Blood Therapeutics, Inc.
Precedenti posizioni note di Stephanie Yao
Società | Posizione | Fine |
---|---|---|
KRONOS BIO, INC. | Investor Relations Contact | - |
LENZ THERAPEUTICS, INC. | Investor Relations Contact | - |
GLOBAL BLOOD THERAPEUTICS, INC. | Investor Relations Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
KRONOS BIO, INC. | Health Technology |
Aziende private | 2 |
---|---|
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |